An Update on Copper-ATSM and Clinical Trials for ALS, Updated March 2017

Friends and followers of the Linus Pauling Institute,

My name is Joseph Beckman, a principal investigator at the Linus Pauling Institute that works on ALS (aka Lou Gehrig’s disease). Without repeating myself too much, I would like to point everyone to a summary of our advances in ALS research that came out in early 2016, shortly after our paper on Copper-ATSM was published. A post on the ALS research forum presents a good, independent summary of that  work.

Since then, the response from the ALS community has been extremely touching. Regrettably, I have fallen far behind in answering the requests from patients and their families, but I want to start making amends by taking this moment to update everyone on several developments in this field.

Continue reading An Update on Copper-ATSM and Clinical Trials for ALS, Updated March 2017

Summary for ALS Patients about CuATSM and Clinical Trials

Joe Beckman, PhD - ALS reseacher

 

Below is an open letter from LPI researcher Joe Beckman to ALS patients who are interested in hearing more about the next steps of his groundbreaking finding released last week that halted the progression of ALS in mice. 

Continue reading Summary for ALS Patients about CuATSM and Clinical Trials